Natera | Transforming Management of Genetic Disease.

State-of-the-art genetic tests for oncology, organ transplantation, and women's health.

Natera receives final Medicare coverage for Prospera transplant assessment test

Natera receives final Medicare coverage for Prospera transplant assessment test

Personalized testing for each cancer patient, to detect molecular residual disease (MRD) and help guide treatment decisions.

The most precise cell-free DNA (cfDNA) testing in organ transplantation—developed from our trusted legacy.

Solutions for all the steps in your journey to parenthood, from starting to plan a family to checking your baby’s health.

Panorama NIPT achieves 2 million test milestone.

“What I love most about Natera is their patient-centered approach to products and services.”

Sheetal Parmar, Clinical Support Director

Natera's core technology and finely tuned workflows cut through the noise to deliver superior clinical and analytical performance.